“The Summit was a fantastic meeting. It was an exciting opportunity to connect with colleagues and collaborators and to discuss the cutting-edge developments in protein drug immunogenicity.”

Brandon DeKosky, PhD, Assistant Professor, The University of Kansas

“Extremely high-quality presentations and excellent networking opportunities. Feedback from the FDA was invaluable”

Alessandro Sette, Dr. Biol. Sci., Professor, Head and Member, La Jolla Institute for Immunology

“I learned a lot about bioanalytical challenges and needs on novel modalities, which ultimately translates into faster drug products delivered to those that need them.”

Lilia Macovei, PhD, Bioanalytical Principal Investigator, Senior Scientist, Pfizer

“The Immunogenicity & Bioassay Summit was a real success. It was a very nice opportunity to meet talented scientists in the field.”

Bernard Maillere, PhD, Research Director, Immunology, CEA

“Breakout interaction with FDA experts was very valuable.”

- Associate Director, Alexion Pharmaceuticals Inc.

“Interesting new data and very relevant to the field.”

- Senior Scientist, Process Development, Amgen, Inc.

“Program and participants first class.”

- Associate Director, Novo Nordisk